NDC 36987-3091
Black Willow
Black Willow
Black Willow is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Salix Nigra Pollen.
| Product ID | 36987-3091_f24271d4-4949-4a67-80d1-62f5885e9407 |
| NDC | 36987-3091 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Black Willow |
| Generic Name | Black Willow |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Nelco Laboratories, Inc. |
| Substance Name | SALIX NIGRA POLLEN |
| Active Ingredient Strength | 0 g/mL |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 36987-3091-3
30 mL in 1 VIAL, MULTI-DOSE (36987-3091-3)
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 36987-3091-4 [36987309104]
Black Willow INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-3091-1 [36987309101]
Black Willow INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-3091-3 [36987309103]
Black Willow INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-3091-2 [36987309102]
Black Willow INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| SALIX NIGRA POLLEN | .05 g/mL |
OpenFDA Data
NDC Crossover Matching brand name "Black Willow" or generic name "Black Willow"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 36987-3085 | Black Willow | Black Willow |
| 36987-3086 | Black Willow | Black Willow |
| 36987-3087 | Black Willow | Black Willow |
| 36987-3088 | Black Willow | Black Willow |
| 36987-3089 | Black Willow | Black Willow |
| 36987-3090 | Black Willow | Black Willow |
| 36987-3091 | Black Willow | Black Willow |
| 36987-3092 | Black Willow | Black Willow |
| 49288-0610 | Black Willow | Black Willow |
| 0268-6796 | SALIX NIGRA POLLEN | Black Willow |
Trademark Results [Black Willow]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BLACK WILLOW 88472127 not registered Live/Pending |
Black Willow, Inc. 2019-06-13 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.